Home › Calculator › PRCWF Dividend Calculator 2026
PRCWF Dividend DRIP Calculator 2026
2000000.00% YieldHealthcareSofgen Pharma S.A. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PRCWF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your PRCWF snowball 📈
$10,000 in PRCWF → $4.392409808550042e+40M in 10 years · $3,660,120,601,263,277,000,000,000,000,000,000,000,000,000,000.00/month
About Sofgen Pharma S.A. (PRCWF) — Dividend Analysis 2026
Sofgen Pharma S.A., through its various subsidiaries, is engaged in the development, manufacturing, and commercialization of pharmaceutical products across South America, Central America, North America, and Europe. The company’s operations are segmented into five distinct divisions: NextGel, Procaps Colombia, Central America North (CAN), Central America South and North Andes (CASAND), and Diabetrics. The firm specializes in formulating, producing, and selling branded prescription medications for a wide range of therapeutic conditions. These include feminine health, pain management, dermatological issues, digestive disorders, growth and development, cardiovascular diseases, vision care, central nervous system ailments, and respiratory illnesses. Sofgen Pharma also supplies pharmaceuticals for hospital use, such as blood clot treatments, immunosuppressants, oncology drugs, and analgesics. Additionally, its hospital-grade offerings encompass medical devices like personal protective equipment (PPE), various types of syringes (including double-chamber designs), injection vials, ampoules, sterilized powder products, sterile droppers, and lyophilized solid vials. Furthermore, the company boasts a robust portfolio of over-the-counter (OTC) consumer healthcare products, spanning approximately eight therapeutic categories. These include solutions for gastrointestinal issues, skincare, cough and cold symptoms, pain relief, and urological health. Its extensive range also features vitamins, minerals, and dietary supplements, as well as pharmaceuticals addressing diverse medical needs across categories such as antibiotics, anti-infectives, antiparasitics, cardiovascular agents, women's health, cutaneous antimycotics, hormonal treatments, metabolic and endocrine system drugs, nervous system medications, ophthalmic preparations, osteoarticular remedies, and respiratory aids. Beyond these product lines, Sofgen Pharma delivers comprehensive diabetes care and chronic disease management solutions. This includes blood glucose monitoring devices, telemonitoring services, oral antidiabetic medications, cosmeceuticals, and insulin delivery systems. The company also extends its expertise through contract development and manufacturing (CDMO) services, particularly in soft gelatin capsule and gummy technologies, under the brand names Softigel, Sofgen, Softcaps, and Funtrition. Established in 1977 and headquartered in Luxembourg, Luxembourg, Sofgen Pharma S.A. was previously known as Procaps Group S.A.
Compare PRCWF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PRCWF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PRCWF position with:
🌍 PRCWF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PRCWF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1600000.00% | 1599997.20% | $160,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1825000.00% | 1824997.20% | $182,500,000 / yr |
| 🇨🇦 TFSA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 1500000.00% | 1499997.20% | $150,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1472500.00% | 1472497.20% | $147,250,000 / yr |
| 🇫🇷 FR Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PRCWF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PRCWF Dividend Payment Schedule
PRCWF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 PRCWF vs Healthcare Benchmarks
How PRCWF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PRCWF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PRCWF Insider Activity
No recent SEC filings reported in the last 90 days.Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PRCWF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Sofgen Pharma S.A. (PRCWF) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 2000000.00% based on an annual payout of $2.00 per share.
PRCWF (Sofgen Pharma S.A.) — 2000000.00% Dividend Yield Analysis
Sofgen Pharma S.A. (PRCWF) is a healthcare stock currently trading at $0.00 with a dividend yield of 2000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (2000000.00%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.